Studies on the Mechanism of Telavancin Decreased Susceptibility in a Laboratory-Derived Mutant

Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies

(2012) Yang Song et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300

(2012) Susana Gardete et al.   PLoS Pathogens

walKandclpPMutations Confer Reduced Vancomycin Susceptibility inStaphylococcus aureus

(2011) Mitsutaka Shoji et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2011) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Staphylococcus aureus KdpDE Two-Component System Couples Extracellular K+Sensing and Agr Signaling to Infection Programming

(2011) Ting Xue et al.   INFECTION AND IMMUNITY

Coordinated Regulation by AgrA, SarA, and SarR To Control agr Expression in Staphylococcus aureus

(2011) D. Reyes et al.   JOURNAL OF BACTERIOLOGY

Peptidoglycan Crosslinking Relaxation Plays an Important Role in Staphylococcus aureus WalKR-Dependent Cell Viability

(2011) Aurelia Delaune et al.   PLoS One

Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carotenoid-Related Alteration of Cell Membrane Fluidity ImpactsStaphylococcus aureusSusceptibility to Host Defense Peptides

(2010) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increased Mortality with Accessory Gene Regulator (agr) Dysfunction inStaphylococcus aureusamong Bacteremic Patients

(2010) Marin L. Schweizer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phenol-Soluble Modulins of Staphylococcus aureus Lure Neutrophils into Battle

(2010) Simon R. Clarke   Cell Host & Microbe

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies

(2009) K. Kosowska-Shick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

(2009) C. S. Lunde et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Waves of resistance: Staphylococcus aureus in the antibiotic era

(2009) Henry F. Chambers et al.   NATURE REVIEWS MICROBIOLOGY

Quorum Sensing in Staphylococci

(2008) Richard P. Novick et al.   Annual Review of Genetics

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

(2008) D. C. Draghi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Insertional Inactivation of Branched-Chain  -Keto Acid Dehydrogenase in Staphylococcus aureus Leads to Decreased Branched-Chain Membrane Fatty Acid Content and Increased Susceptibility to Certain Stresses

(2008) V. K. Singh et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism ofStaphylococcus aureus

(2008) R. Lamichhane-Khadka et al.   JOURNAL OF APPLIED MICROBIOLOGY

Membrane lipid homeostasis in bacteria

(2008) Yong-Mei Zhang et al.   NATURE REVIEWS MICROBIOLOGY